Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Enanta Pharmaceuticals, Inc.(ENTA) | 2,866,138 | 2,866,138 | 0 | $36.2K | $41.8K | 15.88% | +$5.6K |
| Jazz Pharmaceuticals plc(JAZZ) | 167,816 | 167,816 | 0 | $31.7K | $40.4K | 15.36% | +$8.7K |
| United Therapeutics Corporation(UTHR) | 84,282 | 69,282 | -15,000 | $50.0K | $37.5K | 14.26% | -$12.4K |
| BioMarin Pharmaceutical Inc.(BMRN) | 524,786 | 524,786 | 0 | $29.6K | $30.0K | 11.41% | +$383 |
| Exelixis, Inc.(EXEL) | 415,693 | 370,693 | -45,000 | $17.8K | $20.2K | 7.66% | +$2.3K |
| Abbott Laboratories | 5,000 | 200,000 | +195,000 | $513 | $18.1K | 6.89% | +$17.6K |
| Sanofi(SNY) | 323,946 | 323,946 | 0 | $15.6K | $13.8K | 5.25% | -$1.8K |
| Supernus Pharmaceuticals, Inc.(SUPN) | 280,681 | 280,681 | 0 | $14.5K | $13.1K | 4.96% | -$1.5K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 390,879 | 390,879 | 0 | $8.2K | $13.1K | 4.96% | +$4.9K |
| Vanda Pharmaceuticals Inc.(VNDA) | 1,180,388 | 1,180,388 | 0 | $8.2K | $7.2K | 2.74% | -$932 |
| BioNTech SE(BNTX) | 59,523 | 59,523 | 0 | $5.3K | $5.5K | 2.10% | +$249 |
| GSK plc(GSK) | 96,729 | 96,729 | 0 | $5.3K | $5.1K | 1.93% | -$267 |
| Biogen Inc.(BIIB) | 20,000 | 20,000 | 0 | $3.7K | $4.3K | 1.64% | +$654 |
| Regeneron Pharmaceuticals, Inc.(REGN) | 4,000 | 6,000 | +2,000 | $3.1K | $3.7K | 1.42% | +$650 |
| Embecta Corp.(EMBC) | 735,340 | 1,135,340 | +400,000 | $6.5K | $3.7K | 1.41% | -$2.8K |
| Ardelyx Inc | 500,000 | 534,523 | +34,523 | $3.0K | $2.7K | 1.04% | -$269 |
| InMode Ltd.(INMD) | 120,942 | 120,942 | 0 | $1.7K | $1.8K | 0.67% | +$114 |
| Evolus, Inc.(EOLS) | 157,985 | 157,985 | 0 | $649 | $1.1K | 0.42% | +$447 |
| Alkermes plc(ALKS) | 107,822 | 0 | -107,822 | $3.8K | $0 | — | -$3.8K |
| Indivior Pharmaceuticals, Inc.(INDV) | 339,532 | 0 | -339,532 | $10.3K | $0 | — | -$10.3K |